D. Spaëth

1.2k total citations
36 papers, 554 citations indexed

About

D. Spaëth is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, D. Spaëth has authored 36 papers receiving a total of 554 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in D. Spaëth's work include Cancer Treatment and Pharmacology (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). D. Spaëth is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Lung Cancer Treatments and Mutations (9 papers) and Colorectal Cancer Treatments and Studies (5 papers). D. Spaëth collaborates with scholars based in France, Italy and Japan. D. Spaëth's co-authors include Bernhard Weber, Thierry Conroy, C. Clary, Éric Legouffe, Alain Lortholary, R. Gervais, Claire Cropet, R. Foelster‐Holst, Paul Rebattu and Jean-Luc Breton and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

D. Spaëth

35 papers receiving 524 citations

Peers

D. Spaëth

ONCOL

PRM

DERMA

Hans Joachim Gath Germany

Kaori Fujimoto-Ouchi United States

Ingo Hartlapp Germany

Gopal Ramakrishnan India

Kim Leitzel United States

Jianqiu Wu China

Hajime Hirano Japan

M. Walraven Netherlands

Xiao Lin China

Thuy Trinh Germany

Hans Joachim Gath Germany

D. Spaëth

296 ×0.9

ONCOL

115 ×0.4

PRM

135 ×1.2

133 ×1.4

19 ×0.4

DERMA

Citations per year, relative to D. Spaëth D. Spaëth (= 1×) peers Hans Joachim Gath

Countries citing papers authored by D. Spaëth

Since Specialization

Citations

This map shows the geographic impact of D. Spaëth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Spaëth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Spaëth more than expected).

Fields of papers citing papers by D. Spaëth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Spaëth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Spaëth. The network helps show where D. Spaëth may publish in the future.

Co-authorship network of co-authors of D. Spaëth

This figure shows the co-authorship network connecting the top 25 collaborators of D. Spaëth. A scholar is included among the top collaborators of D. Spaëth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Spaëth. D. Spaëth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rouge, Thibault De La Motte, M-A Mouret-Reynier, Bernard Asselain, et al.. (2020). 823P Extended follow-up of a real-world cohort of patients (pts) with BRCA mutation (BRCAm) relapsed epithelial ovarian cancer (EOC) receiving olaparib maintenance therapy: The GINECO RETROLA study. Annals of Oncology. 31. S621–S622. 1 indexed citations

Pivot, Xavier, Jean‐Philippe Spano, Marc Espié, et al.. (2017). Patients' preference of trastuzumab administration (subcutaneous versus intravenous) in HER2-positive metastatic breast cancer: Results of the randomised MetaspHer study. European Journal of Cancer. 82. 230–236. 51 indexed citations

Angelergues, Antoine, Alison Birtle, Orazio Caffo, et al.. (2016). Efficacy of cabazitaxel, abiraterone, enzalutamide and docetaxel sequence in men with metastatic castration-resistant prostate cancer (mCRPC) in real life practice: The multinational, retrospective, observational CATS study. Annals of Oncology. 27. vi252–vi252. 2 indexed citations

Houédé, Nadine, Gottfried J. Locker, Héctor Soto Parrà, et al.. (2016). Epicure: a European epidemiological study of patients with an advanced or metastatic Urothelial Carcinoma (UC) having progressed to a platinum-based chemotherapy. BMC Cancer. 16(1). 752–752. 5 indexed citations

Treilleux, Isabelle, Mónica Arnedos, Claire Cropet, et al.. (2014). Translational studies within the TAMRAD randomized GINECO trial: evidence for mTORC1 activation marker as a predictive factor for everolimus efficacy in advanced breast cancer. Annals of Oncology. 26(1). 120–125. 68 indexed citations

Granel‐Brocard, F., J.-F. Cuny, P. Tréchot, et al.. (2010). Ulcérations des membres inférieurs sous sunitinib. Annales de Dermatologie et de Vénéréologie. 137(10). 626–629. 4 indexed citations

Spaëth, D.. (2010). Époétine bêta dans le traitement de l'anémie liée à la chimiothérapie dans les tumeurs solides et les hémopathies malignes. Résultats d'un essai clinique, en ouvert, multicentrique. Bulletin du Cancer. 97(8). 969–978. 2 indexed citations

Otten, S L, et al.. (2006). Reduced Cellular Toxicity of a New Silver-Containing Antimicrobial Dressing and Clinical Performance in Non-Healing Wounds. Skin Pharmacology and Physiology. 19(3). 140–146. 50 indexed citations

Foelster‐Holst, R., et al.. (2005). Efficacy of Crisis Intervention Treatment with Topical Corticosteroid Prednicarbat with and without Partial Wet-Wrap Dressing in Atopic Dermatitis. Dermatology. 212(1). 66–69. 24 indexed citations

10.

Pujol, Jean-Louis, Jean-Luc Breton, R. Gervais, et al.. (2005). Gemcitabine–docetaxel versus cisplatin–vinorelbine in advanced or metastatic non-small-cell lung cancer: a phase III study addressing the case for cisplatin. Annals of Oncology. 16(4). 602–610. 101 indexed citations

11.

Giaccone, Giuseppe, Egbert F. Smit, Maja J.A. de Jonge, et al.. (2004). Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer. European Journal of Cancer. 40(5). 667–672. 27 indexed citations

12.

Douillard, Jean‐Yves, R. Gervais, G Dabouis, et al.. (2004). Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel–cisplatin versus vinorelbine–cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study. Annals of Oncology. 16(1). 81–89. 31 indexed citations

13.

Weber, Bernhard, et al.. (2000). Brain metastases from epithelial ovarian carcinoma. International Journal of Gynecological Cancer. 10(5). 366–371. 45 indexed citations

14.

Peiffert, D., et al.. (2000). La curiethérapie endobronchique de haut débit de dose: un traitement curatif. Cancer/Radiothérapie. 4(3). 197–201. 4 indexed citations

15.

Douillard, Jean‐Yves, R. Gervais, H. Lacroix, et al.. (2000). Preliminary results of a randomized study on first and second line chemotherapy strategy in stage IV non-small cell lung cancer (NSCLC), assessing docetaxel (D) and cisplatin (C) until progressive disease (PD) then vinorelbine (V) versus V-C until PD then D. Lung Cancer. 29(1). 91–92. 2 indexed citations

16.

Spaëth, D., et al.. (1999). Syndrome de Pancoast-Tobias révélant un lymphome non hodgkinien pulmonaire primitif. La Revue de Médecine Interne. 20(11). 1028–1030. 2 indexed citations

17.

Spaëth, D., et al.. (1997). Phase II studies of two trial regimens of topotecan as second-line single agent therapy in advanced breast cancer. European Journal of Cancer. 33. S158–S158. 5 indexed citations

18.

Marchal, C., et al.. (1996). Particularités diagnostiques et thérapeutiques du cancer du sein de la femme âgée. Groupe Sein du Centre Alexis Vautrin.. La Presse Médicale. 25(34). 1 indexed citations

19.

Bardet, É., Jean‐Yves Douillard, A. Riviére, et al.. (1996). 2139 Chemotherapy followed by a combination of daily irradiation and carboplatine (CBDCA) in stage IIIB non small cell lung cancer (NSCLC): First interim analysis of a phase II trial. International Journal of Radiation Oncology*Biology*Physics. 36(1). 345–346. 1 indexed citations

20.

Marchal, C., et al.. (1996). [Diagnostic and therapeutic characteristics of breast cancer in elderly women. Groupe Sein du Centre Alexis Vautrin].. PubMed. 25(34). 1636–42. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact